Board of Directors

Business Experience

Ms. Boor is the Dean of the Graduate School and Vice Provost for Graduate Education at Cornell University. Serving in this role since 2020, Ms. Boor is the chief academic and administrative officer for Cornell’s Graduate School, where she is responsible for oversight of more than eighty graduate fields populated by more than 5,000 research Masters, Ph.D., and professional degree students. From 2010 until 2020, she served as the Ronald P. Lynch Dean of the College of Agriculture and Life Sciences at Cornell University; Cornell’s second largest college with an annual operating budget of ~$500 million. Ms. Boor also served as Chair of the Food Science Department from 2007 until 2010, and as a Food Science professor, leading active research laboratories from 1994 until 2020, garnering millions of dollars in competitive funding from the National Institutes of Health, the USDA, and the US Sea Grant program, among others.

Education

Ms. Boor earned a B.S. in Food Science from Cornell University, an M.S. in Food Science from the University of Wisconsin and a Ph.D. in Microbiology from the University of California, Davis.

Qualifications

Ms. Boor brings to the Board extensive knowledge of food and beverage science, including expertise in molecular biology, food safety and quality. Until assuming her current role in October 2020, Ms. Boor was responsible for developing and implementing the strategic direction of Cornell’s College of Agriculture and Life Science and made important contributions in food and beverage research.

Public Board Memberships

• Seneca Foods Corporation, a food processing company
• Sarepta Therapeutics, Inc., a biopharmaceutical company that develops drugs to treat life-threatening diseases

Additional Accomplishments and Memberships

• Board Member, US-Israel Binational Agricultural Research and Development Fund
• USAID Feed the Future, Chair, Food Safety Innovation Lab Advisory Committee
• Fellow, American Association for the Advancement of Science
• Fellow, Institute of Food Technologists
• Fellow, American Academy of Microbiology
• Fellow, International Academy of Food Science and Technology

Business Experience

Mr. Costa has been Chief Executive Officer and Chair of the Board of Directors of Eastman Chemical Company since 2014. Since joining Eastman in 2006, he has held a number of executive positions and has been instrumental in developing the strategies, strengthening the capabilities, and building a growth and outcome-oriented culture that have led to the company’s innovative growth. In 2006, Mr. Costa joined Eastman’s executive team as Chief Marketing Officer and leader of corporate strategy and business development. He was named Executive Vice President and assumed profit and loss responsibilities for the Specialty Plastics and Performance Polymers businesses in addition to his prior responsibilities in 2008. The following year, his role was expanded to lead the specialty products businesses. During this time, he also served as Chief Marketing Officer and had executive responsibility for global integrated supply chain and Eastman’s global innovation and sustainability initiatives. In 2013, Mr. Costa was appointed President of Eastman and served in that position until he became Chief Executive Officer. Before joining Eastman, Mr. Costa was a senior partner with Monitor Group, a global management consulting firm. He played a crucial role in developing Monitor’s techniques in corporate transformations and portfolio management and designing client business and marketing capability building programs.

Education

Mr. Costa earned his Bachelor of Science Degree in Economics from University of California, Berkeley and his MBA from Harvard Business School.

Qualifications

Through serving in a number of executive positions at Eastman and being instrumental in developing Eastman’s growth strategies for its businesses, Mr. Costa’s unique knowledge of the opportunities and challenges associated with Eastman, as well as of the chemical industry and various market participants, makes him uniquely qualified to lead and advise the Board of Directors.

Public Board Memberships

• Eastman Chemical Company, a chemical company

Additional Accomplishments and Memberships

• Recipient of International Palladium Medal by the Société de Chimie Industrielle (2022)
• Executive Committee Member of American Chemistry Council
• FOSSI Advisory Board
• Member of Business Council
• Board Member of Business Roundtable (2025)
• Member of Society of Chemical Industry

Business Experience

Ms. Drosos served as the Chief Executive Officer of Signet Jewelers Ltd. (“Signet”), the world’s largest retailer of diamond jewelry, from August 2017 to November 2024. During her tenure, she led Signet through a significant transformation, expanding its digital capabilities and enhancing the customer experience to deliver total shareholder returns more than five times the retail industry average. Prior to her role at Signet, Ms. Drosos was Chief Executive Officer of Assurex Health, Inc. (“Assurex”), where she delivered significant revenue growth and executed the strategic sale of the company. Prior to Assurex, she spent 25 years at The Procter & Gamble Company, including as Group President Global Beauty, where she established herself as a transformative leader who led game changing innovation, built multibillion-dollar brands, and reinvented global categories.

Education

Ms. Drosos holds a Bachelor of Business Administration from the Terry School, University of Georgia, and a Master of Business Administration from the Wharton School, University of Pennsylvania.

Qualifications

Ms. Drosos brings extensive relevant experience, deep consumer insights and a proven ability to drive innovation and lead with purpose, which aligns with our long-term strategy to deliver sustainable growth and value creation for all stakeholders. She also has significant public company board experience.

Public Board Memberships

• Board Director, Foot Locker, Inc., a multinational retailer of footwear, sportswear, and urban youth apparel
• Former Board Director, Signet Jewelers Ltd. from 2012 to 2024
• Former Board Director, American Financial Group Inc. from 2013 to 2021

Additional Accomplishments and Memberships

• Executive Committee, Foundation Chair and Chair Leadership Development and Compensation Committee for the United States Golf Association (USGA), a leading golf organization whose purpose is to unify, showcase, govern, and advance the game of golf with a focus on driving sustainability, accessibility and inclusion
• Former Board Director Akron Children’s Hospital
• Former Board Member of Back2Back Ministries, an international non-profit organization
• Forbes 50 over 50 (2024)
• Top 50 Women CEOs by Women We Admire (2022)

Business Experience

Mr. Ferraro was the Global Chief Operating Officer of Ernst & Young (EY), a global professional services organization, from 2007 to January 2015. In that role, he was responsible for the overall operations and services of EY worldwide. Prior to the Global Chief Operating Officer role, Mr. Ferraro served in several leadership positions, including Global Vice Chair of Audit and as the senior advisory partner on some of the firm’s largest accounts. He began his career with EY Milwaukee in 1976 and has served a variety of global companies. Mr. Ferraro was the Executive Vice President, Strategy and Sales of Aquilon Energy Services, a software company for the energy industry, from February 2019 to July 2019.

Education

Mr. Ferraro earned his Bachelor of Science in Business Administration from Marquette University

Qualifications

Mr. Ferraro brings to our Board his significant depth in both finance and global operations management through his experience with large and global corporations while working at EY. He has an extensive background as a manager and executive in the professional services industry. We benefit from Mr. Ferraro’s significant experience in accounting, financial oversight, compliance and risk management, which enables him to assist the Board in identifying trends and developments that affect public companies. He also brings his cybersecurity experience based on his past employment position where he supervised the chief information officer and was involved in the development of the company’s cyber practice.

Public Board Memberships

• Advance Auto Parts, Inc., an automotive aftermarket parts provider
• ManpowerGroup Inc., a global workforce solution and service provider

Additional Accomplishments and Memberships

• Board Member of TEI Group Holdings LP, which purchased Triumvirate Environmental Inc. at the end of 2024, a provider of waste management and environmental solutions
• Founder of RP Intellectual Partners LLC (a successor to a part of Alpha Alpha Intellectual Properties, LLC), a firm investing in intellectual properties focused on technology
• Former Member of the Global Executive Board of Ernst & Young from 2001 until 2002 and 2004 until 2014
• Trustee Emeritus of Marquette University
• Former Chair of the Board of Trustees of Boston College High School
• Founder of the Audit Committee Leadership Network
• Practiced as a CPA and is a member of the American Institute of Certified Public Accountants

Business Experience

Paul Fribourg brings more than four decades of global leadership experience in the agribusiness, food, and investment sectors, and currently serves as Chairman and Chief Executive Officer of Continental Grain Company (“Conti”), a position he has held since 1997. Mr. Fribourg has overseen Conti’s transformation into a diversified global investment firm with a focus on food, agriculture, and adjacent industries. Under Mr. Fribourg’s leadership, Conti has expanded its portfolio and strategic partnerships across continents, reinforcing its legacy of innovation and resilience.

Education

Mr. Fribourg earned a Bachelor of Arts degree, magna cum laude, from Amherst College and completed the Advanced Management Program at Harvard Business School.

Qualifications

Mr. Fribourg brings a strong combination of global market insight and operational excellence. His experience, leadership and vision will help guide the Company through its next phase of growth as it continues to deliver breakthrough solutions for customers and create long-term value for its stakeholders.

Public Board Memberships

• Loews Corp., a diversified company, with businesses in the insurance, energy, hospitality and packaging industries, since 1997
• Estee Lauder Companies Inc., a Global Leader in Prestige Beauty, since 2006

Additional Accomplishments and Memberships

• Board Chair of Continental Grain Company, an agribusiness investment company, since 1976
• Board Member of Syngenta Group Co. Ltd., a global agricultural technology and innovation company, since 2018
• Board Member of Wayne-Sanderson Farms LLC, poultry producer, since 2011
• Member of the Rabobank International North American Agribusiness Advisory Board
• Member of the Council on Foreign Relations
• Member the Temasek Americas Advisory Panel
• Member of the International Business Leaders Advisory Council for the mayor of Shanghai

Business Experience

Mr. Fyrwald has served as our Chief Executive Officer and a member of our Board of Directors since February 6, 2024. He joined us from Syngenta, where he served as Chief Executive Officer since 2016. Prior to his role at Syngenta, Mr. Fyrwald served as Chief Executive Officer of Univar Solutions from May 2012 until May 2016, Chairman and Chief Executive Officer of Nalco from 2008 until 2011, when Nalco merged with Ecolab Inc. Following the merger, he served as President of Ecolab. Mr. Fyrwald began his career at DuPont starting in 1981. During his 27-years at DuPont, Mr. Fyrwald held a number of positions, including Group Vice President of the Agriculture and Nutrition Division at E.I. du Pont de Nemours and Company and Vice President and General Manager of DuPont’s Nutrition and Health Business.

Education

Mr. Fyrwald attended the University of Delaware, where he received a Bachelor of Science in Chemical Engineering in 1981. He also completed the Advanced Management Program at Harvard Business School in 1998.

Qualifications

Mr. Fyrwald has more than four decades of executive and operational experience driving innovation and profitable, sustainable growth at leading corporations in the nutrition, agriculture and chemicals industries.

Public Board Memberships

• Eli Lilly and Company, a pharmaceutical company that develops, manufactures and sells prescription drugs and other healthcare products

Additional Accomplishments and Memberships

• Chairman, Council on Competitiveness
• Former Board Member of Syngenta Group
• Former Chair for Crop Life International
• Former Chair for Nalco
• Former Board Member of Bunge
• Former Board Member of Syngenta Foundation
• Former Board Member of Swiss-American Chamber of Commerce
• Former Board Member of UN World Food Program Farm to Market Alliance

Business Experience

Brett Icahn is an investor and portfolio manager at Icahn Capital, a subsidiary of Icahn Enterprises. Icahn Enterprises is a diversified holding company engaged in a wide range of sectors, including investment, automotive, energy, food packaging, real estate, and home fashion. Since October 2020, Mr. Icahn has played a leading role in managing the investment strategy for Icahn Capital. 

Education

Mr. Icahn holds a Bachelor of Arts from Princeton University.

Qualifications

Mr. Icahn brings a sharp investment acumen and deep understanding of corporate strategy and his experience will be very valuable to the Company. 

Public Board Memberships

• SandRidge Energy, Inc., an independent oil and natural gas companyfocused on the acquisition, development, and production of oil and gas properties
• CVR Energy, a diversified holding company that operates in the petroleum refining and marketing, renewable fuels, and nitrogen fertilizer businesses
• Icahn Enterprises LP, a diversified holding company that owns a variety of subsidiaries operating in different sectors, from 2020 to 2025
• Bausch Health Companies Inc., a global diversified pharmaceutical company, from 2021 to 2025
• Bausch + Lomb Corporation, an eye health company, from 2022 to 2025
• Dana Inc.,an automotive supplier company, from 2022 to 2023 and January 2025 to June 2025
• Newell Brands Inc.a global marketer of consumer and commercial products, from 2018 to 2023
• Take-Two Interactive Software Inc., an American video game holding company, from 2010 to 2013
• The Hain Celestial Group, Inc., an organic and natural products company, from 2010 to 2013
• Voltari Corporation, a mobile data services provider, from 2010 to 2014.

Additional Accomplishments and Memberships

• Former board member, American Railcar Industries, Inc.
• Former board member, Cadus Corporation
• Former board member, Nuance Communications, Inc.

Business Experience

Ms. Jamison served as the Chief Financial Officer of AquaSpy lnc., an Australian environmentally responsible irrigation company, from 2009 until 2013. Previously, Ms. Jamison served as a partner with Tatum, LLP from June 1999 through May 2009. She has been the Chief Financial Officer or Chief Operating Officer of several publicly and privately held companies including eMac, lnc, a joint venture between McDonald’s Corporation and KKR & Co. L.P., Cosi, lnc., the casual dining chain, SurePayroll, a payroll processing firm, and Illinois Superconductor, a radio frequency cellular technology company. From 2006 on, Ms. Jamison was in a Managing Partner role within Tatum, LLP, and served in several additional capacities, including as Managing Partner of the CFO Services practice where she led 300+ CFO partners and sat on the firm’s Operating Committee. Prior to her CFO roles, Ms. Jamison held Executive/Financial leadership roles at Arthur Andersen, Kraft General Foods, Hewitt Associates, Allied Domecq (Dunkin’ Donuts/Baskin Robbins) and Chart House Enterprises.

Education

Ms. Jamison earned a B.A. in Political Science and Economics from Duke University and an MBA from the University of Chicago in Finance. Ms. Jamison is also a certified public accountant.

Qualifications

Ms. Jamison is a skilled Chief Financial Officer with extensive board and finance experience gained during previous executive positions.

Public Board Memberships

• The ODP Corporation, a leading provider of office products
• Darden Restaurants, a hospitality company
• Tractor Supply Company, a retail company, from 2002 to 2023
• B&G Foods, an American branded foods company, from 2004 to 2015

Additional Accomplishments and Memberships

• Board Member of Save the Children
• Former Board Member of Big Lots, Inc.
• Former Board Member of Cellu Tissue Holdings, Inc
• Former Board Member of Horizon Organic Holding Corporation
• Completed a four-year term as a member of FASAC, the advisory board to the Financial Accounting Standards Board (FASB)
• NACD Board Leadership Fellow and awarded the ‘‘Top 100 Director’’ honor in 2017
• Frequent keynote speaker on topics related to CFO and board governance
• Quoted as a financial/economic expert in Forbes, The Wall Street Journal, Newsweek, CFO Magazine, Agenda, Board Member and The Economist

Business Experience

Mr. Khan is the CEO of Hevolution Foundation, a first-of-its-kind global non-profit organization with a mission to extend healthy lifespan for people everywhere. He was the Executive Chair of Life Biosciences after serving as the CEO from 2019 until 2024. Prior to this role, Mr. Khan served as PepsiCo’s Vice Chairman and Chief Scientific Officer of Global Research and Development. Prior to joining PepsiCo, he was President of Takeda Global Research & Development Center, overseeing Takeda Pharmaceuticals Company’s worldwide R&D efforts. Mr. Khan was also a faculty member at the Mayo Clinic and Mayo Medical School, serving as Director of the Diabetes, Endocrine and Nutritional Trials Unit in the endocrinology division. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition for the Hennepin County Medical Center.

Education

Mr. Khan has a medical degree from the University of Liverpool, is a Fellow of the Royal College of Physicians, London and of the American College of Endocrinology, an Elected Fellow in the Department of Pharmacology at University of Oxford and holds two Honorary Ph.D.s in Humanities and International Law.

Qualifications

Mr. Khan is a highly skilled medical practitioner and researcher with extensive experience in both developing and developed markets. He has a deep knowledge of creating sustainable initiatives and track record of leading research and development efforts to create breakthrough innovations.

Public Board Memberships

• Reckitt Benckiser, a multinational company that manufactures and markets products for the home, health and personal care
• CorMedix Inc., a biopharmaceutical company developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases

Additional Accomplishments and Memberships

• Member of the Board, Research Development & Innovation Authority (RDIA)
• Member of the Saudi National Biotechnology Strategy Steering Committee
• Fellow of the Royal College of Physicians in London
• Fellow of the American College of Endocrinology
• Elected Fellow in the Department of Pharmacology at University of Oxford
• Past Chair, Visiting Committee Advanced Technology, US National Institute Standards and Technology (NIST)

Business Experience

Jesus Mantas led the $10B Business Transformation Services unit of IBM Consulting. Prior to that role, he led Strategy and M&A in IBM Consulting, and led multiple divisions including IBM Global Business Outsourcing, IBM Consulting in Latin America, and North America enterprise market. Before IBM, he was a Partner in the High Technology practice of PricewaterhouseCoopers Consulting, and he served as an adjunct professor at the University of California Irvine. Prior to his move to USA, he worked for Procter & Gamble and served as an officer in the Air Force of Spain.

Education

Mr. Mantas holds degrees in Telecommunications, and Business Administration by Universidad Politécnica de Madrid.

Qualifications

Mr. Mantas brings a strong combination of digital innovation, global market insight and operational excellence. His experience, leadership and vision will help guide the Company through its next phase of growth as it continues to deliver breakthrough solutions for customers and create long-term value for its stakeholders.

Public Board Memberships

• Biogen Inc., a leading biotechnology company

Additional Accomplishments and Memberships

• Board member, National Association of Corporate Directors (NACD)
• Council Member of the Council for Global Competitiveness and Innovation (CGCI.org)
• Vice Chair of the board of directors of nonprofit HITEC
• Former member of the World Economic Forum AI Global Council

Business Experience

Richard Mulligan, Ph.D. is currently the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School, and served as Visiting Scientist at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) from March 2017 to February 2021. From March 2017 to October 2018, Dr. Mulligan served as Portfolio Manager at Icahn Capital, an investment management firm, and from May 2013 to December 2016, he served as Founding Partner and Senior Managing Director of Sarissa Capital Management LP, a registered investment advisor. From 1996 to 2013, Dr. Mulligan served as the Mallinckrodt Professor of Genetics at Harvard and Director of the Harvard Gene Therapy Initiative. Prior to that, he served as Professor of Molecular Biology at MIT and a member of the Whitehead Institute for Biomedical Research. 

Education

Dr. Mulligan received his Ph.D. in Biochemistry from the Stanford University School of Medicine and his B.S. in Biology from MIT.

Qualifications

Dr. Mulligan offers world-class scientific expertise and a track record of innovation that will be valuable as to our Company as we accelerate our transformation and deliver sustainable, long-term value for our customers, shareholders and employees.

Public Board Memberships

• Sana Biotechnology, Inc., a public biotechnology company
• Bausch Health Companies Inc., a public pharmaceutical company
• Biogen Inc., a public biotechnology company, from 2009 to 2023
• Enzon Pharmaceuticals, a pharmaceutical company, from 2011 to 2013
• Cellectis SA, is a clinical-stage biotechnology company, from 2007 to 2013

Additional Accomplishments and Memberships

• Former Director of ImClone Systems LLC, a biopharmaceutical company, from 2006 to 2008
• Former Director of Kadmon Pharmaceuticals LLC, a biopharmaceutical company, from 2010 to 2021
• Recipient, John S. Asinari Award for Undergraduate Research in the Life Sciences, 1976
• Recipient, National Science Foundation Graduate Fellowship, 1976-1979
• Recipient, MacArthur Foundation Prize, 1981
• Recipient, Searle Scholar’s Award, 1983-1986
• Recipient, Rhodes Memorial Award, American Assoc. for Cancer Research, 1991
• Recipient, 1992 M.I.T. Science Council Teaching Prize
• Recipient, 1993 ASBMB-Amgen Award
• Recipient, 1997 Nagai Foundation Tokyo International Prize

Business Experience

Mr. O’Byrne served as Chief Financial Officer and Director of J Sainsbury plc, the second largest retailer in the United Kingdom, from 2017 until March 2023. He was previously Chief Executive Officer of Poundland Group plc until December 2016 and held executive roles at Kingfisher plc from 2008 to 2015, including Divisional CEO/Chair UK, China and Turkey, Chief Executive Officer of B&Q UK & Ireland and Group Finance Director. Prior to this, Mr. O’Byrne was Group Finance Director of Dixons Retail plc and European Finance Director of Quaker Oats.

Education

Mr. O’Byrne holds a Bachelor of Arts in Business Studies from Trinity College Dublin and he has been a Fellow of the Institute of Chartered Accountants in England & Wales since 1990.

Qualifications

Mr. O’Byrne is a skilled Chief Financial Officer with extensive board, international and finance experience gained during previous executive and non-executive positions. He applied this knowledge to the Finance, Internal Audit, Investor Relations, Property, Procurement and Strategy functions at Sainsbury’s, driving the performance of the business. He was the Operating Board Sponsor for the LGBT+ inclusion stream within Sainsbury’s.

Public Board Memberships

• Chair of Centrica plc, an energy and services company
• J Sainsbury plc, the second largest retailer in the United Kingdom, from 2017 to 2023
• Kingfisher plc, an international home improvement company, from 2008 to 2015
• Land Securities Group plc, a commercial property development and investment company in the United Kingdom, from 2008 to 2017

Additional Accomplishments and Memberships

• Campaign Council member Integrated Education Fund

Business Experience

Ms. Willoughby served as the Executive Vice President and Chief Operating Officer of The Clorox Company, a manufacturer and marketer of consumer and professional products, from 2014 until 2019. She also served as the company’s Senior Vice President and General Manager, Clorox Cleaning Division; Vice President and General Manager, Home Care Products; and Vice President and General Manager, Glad Products, along with several other positions since she was initially hired in 2001. Prior to her career at The Clorox Company, Ms. Willoughby spent nine years with The Procter & Gamble Company, where she held several positions in sales management.

Education

Ms. Willoughby holds a bachelor’s degree in Sports Management from the University of Minnesota and a master’s degree in Business Administration from the University of California, Los Angeles Anderson School of Business.

Qualifications

Through serving in a number of executive positions at the Clorox Company and her deep understanding for the unique needs and expectations of our Company’s customers and partners, Ms. Willoughby is valuable to our Board and management team.

Public Board Memberships

• J.M. Smucker Company, a manufacturer and marketer of branded food and beverage products
• TE Connectivity, an engineering, design and manufacturer of sensors and electrical connectivity solutions

Additional Accomplishments and Memberships

• Former Chair for Alameda County Community Food Bank
• Former Board Member of the American Cleaning Institute
• Former Member of the Grocery Manufacturers Association’s Industry Affairs Council
• Named one of the most influential women in the Bay Area by the San Francisco Business Times (May 2013)